dipyrone has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilgenstein, B; Jaquiery, C; Mauermann, E; Ruppen, W; Schneider, T | 1 |
| Elgamasy, S; Ghozy, S; Islam, SMS; Kamel, MG; Khalil, A; Morra, ME | 1 |
| Cohen, E; Goldberg, E; Krause, I; Lerman, TT; Sagi, M; Shafir, Y; Sheena, L | 1 |
1 trial(s) available for dipyrone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Analgesic benefit of metamizole and ibuprofen vs. either medication alone: a randomized clinical trial.
Topics: Analgesics; COVID-19; Cross-Over Studies; Dipyrone; Double-Blind Method; Humans; Ibuprofen; Pain, Postoperative | 2022 |
2 other study(ies) available for dipyrone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
First case of focal epilepsy associated with SARS-coronavirus-2.
Topics: Acetaminophen; Acetylcysteine; Aged; Ambroxol; Anticonvulsants; Cough; COVID-19; COVID-19 Drug Treatment; Dipyrone; Epilepsies, Partial; Female; Fever; Humans; Nasopharynx; Radiography, Abdominal; SARS-CoV-2; Treatment Outcome | 2020 |
A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; COVID-19; Dipyrone; Humans; Neutropenia; SARS-CoV-2 | 2021 |